This infographic shows that controlling potentially mutagenic impurities using Mirabilis, could save organisations an estimated $1.35 million annually, compared to using analytical testing only.
To calculate this estimate we have worked with a Lhasa member using Mirabilis.
We have considered; a medium sized pharmaceutical company, an OPRD paper which estimates the number of impurities introduced within a synthetic route, the Lhasa member’s analytical workflow for testing for impurities and also the resulting time required for each analytical approach. This time estimate has allowed us to generate an expected cost for development.